Author

Seon-Hui Hong

Rockefeller UniversityORCID 0000-0002-0746-9237Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Alison W. AshbrookiD· 2 shared Charles M. RiceiD· 2 shared Margaret R. MacDonaldiD· 2 shared Adam HageiD· 1 shared Ana PinharandaiD· 1 shared Ansgar F. StenzeliD· 1 shared Aurélie CobatiD· 1 shared Avery PeaceiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alison W. AshbrookORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyPLoS PathogensPeer-reviewedApr 21, 2025

Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine

Samantha G. Muccilli, Benjamin H. Schwarz, Byron Shue…·Sonja M. Best

This study identifies mitochondrial hyperactivity and reactive oxygen species as critical drivers of innate immunity to the YFV-17D vaccine, enhancing IFN response and vaccine effectiveness.

23 citationstop 2%

humanmetabolomics

𝕏 PostBluesky

ImmunologyPLoS BiologyPeer-reviewedSep 24, 2024

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist

Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast…·Charles M. Rice

The paper identifies PLSCR1 as a host factor restricting SARS-CoV-2 entry, which recent variants have evolved to bypass, through a CRISPR screen and integration of genetic studies.

20 citationstop 3%

humangenetic perturbation / CRISPR

𝕏 PostBluesky